IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 135 filers reported holding IDENIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $173,149,000 | +282.0% | 7,184,612 | -4.4% | 0.01% | +250.0% |
| Q1 2014 | $45,325,000 | +21.4% | 7,516,729 | +20.4% | 0.00% | +33.3% |
| Q4 2013 | $37,344,000 | +18.7% | 6,244,894 | +3.4% | 0.00% | 0.0% |
| Q3 2013 | $31,468,000 | +48.5% | 6,039,954 | +2.9% | 0.00% | +50.0% |
| Q2 2013 | $21,196,000 | – | 5,871,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 26,767,000 | $96,629,000 | 2.40% |
| Bain Capital Public Equity Management, LLC | 12,664,950 | $45,720,000 | 1.07% |
| Camber Capital Management LP | 2,750,000 | $9,927,000 | 1.02% |
| BRIDGER MANAGEMENT, LLC | 3,260,628 | $11,771,000 | 0.86% |
| BB BIOTECH AG | 1,250,000 | $4,513,000 | 0.32% |
| GENERAL AMERICAN INVESTORS CO INC | 858,979 | $3,101,000 | 0.28% |
| Aris Wealth Services, Inc. | 30,000 | $108,000 | 0.23% |
| AlpInvest Partners B.V. | 56,986 | $206,000 | 0.20% |
| Visium Asset Management, LP | 1,350,000 | $4,874,000 | 0.11% |
| Old West Investment Management, LLC | 57,949 | $209,000 | 0.10% |